Suppr超能文献

成功进行针对因子H相关性溶血尿毒综合征的肝肾联合移植

Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

作者信息

Saland Jeffrey M, Shneider Benjamin L, Bromberg Jonathan S, Shi Patricia A, Ward Stephen C, Magid Margret S, Benchimol Corinne, Seikaly Mouin G, Emre Sukru H, Bresin Elena, Remuzzi Giuseppe

机构信息

Department of Pediatrics, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA.

出版信息

Clin J Am Soc Nephrol. 2009 Jan;4(1):201-6. doi: 10.2215/CJN.02170508. Epub 2008 Nov 12.

Abstract

BACKGROUND AND OBJECTIVES

A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS).

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report.

RESULTS

Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr.

CONCLUSIONS

This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.

摘要

背景与目的

一名有血栓性微血管病家族史的男婴患上了非典型溶血尿毒综合征(aHUS)。

设计、地点、参与者与测量方法:病例报告。

结果

基因分析显示编码补体因子H(CFH)的CFH基因存在杂合突变(S1191L)。该患儿多次发生溶血尿毒综合征,每次发作均接受血浆置换治疗。随着时间推移,尽管开始了血浆置换预防性治疗方案,但其肾功能仍显著下降。4岁时,他接受了(劈离式肝脏)肝肾联合移植(LKT),术前进行了血浆置换和依诺肝素抗凝。两个移植物的初始功能均良好,并维持了近2年。

结论

本报告增加了接受LKT治疗与CFH突变相关的aHUS并取得良好疗效的病例数量,尽管数量不多但仍在增加,扩展了使用劈离式肝脏移植物的技术,并描述了溶血尿毒综合征中亚临床肝脏疾病的独特组织学特征。

相似文献

引用本文的文献

2
Combined liver-kidney transplantation for rare diseases.肝肾联合移植治疗罕见病。
World J Hepatol. 2020 Oct 27;12(10):722-737. doi: 10.4254/wjh.v12.i10.722.
3
Haemolytic uremic syndrome: diagnosis and management.溶血性尿毒症综合征:诊断与管理
F1000Res. 2019 Sep 25;8. doi: 10.12688/f1000research.19957.1. eCollection 2019.
8
Hemolytic uremic syndrome.溶血尿毒综合征
Semin Immunopathol. 2014 Jul;36(4):399-420. doi: 10.1007/s00281-014-0416-x. Epub 2014 Feb 14.
10
Atypical hemolytic uremic syndrome.非典型溶血尿毒综合征。
Semin Nephrol. 2013 Nov;33(6):508-30. doi: 10.1016/j.semnephrol.2013.08.003.

本文引用的文献

4
New approaches to the treatment of dense deposit disease.治疗致密物沉积病的新方法。
J Am Soc Nephrol. 2007 Sep;18(9):2447-56. doi: 10.1681/ASN.2007030356. Epub 2007 Aug 5.
6
Thrombotic microangiopathy and intravenous immunoglobulin therapy.血栓性微血管病与静脉注射免疫球蛋白治疗
Pediatr Nephrol. 2007 Jun;22(6):907-8; author reply 909. doi: 10.1007/s00467-007-0441-2. Epub 2007 Feb 13.
10
Secondary failure of plasma therapy in factor H deficiency.补体因子H缺乏症中血浆疗法的继发性失败
Pediatr Nephrol. 2006 Nov;21(11):1769-71. doi: 10.1007/s00467-006-0237-9. Epub 2006 Aug 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验